The primary objective was to evaluate safety and tolerability of Ropanicant in patients with MDD
Aragen Life Sciences is the first Indian CRDMO to receive SBTi approval
The company will now seek final approval from NCLT, Mumbai Bench, and upon its receipt, OneSource will proceed to seek listing approvals from the BSE and NSE
ALS patients experience neuroinflammation and rapid neurodegeneration
TROPION-Lung01, evaluating AstraZeneca and Daiichi Sankyo’s datopotamab deruxtecan versus chemotherapy, previously met the dual primary endpoint of progression-free survival in the overall trial population
Phase 3 study results will form the basis for future discussions with global regulatory authorities
The study highlighted substantial improvements in key clinical parameters among RA patients who underwent AWS intervention
First patient enrolled in the Phase III SOHO-02 trial of investigational agent BAY 2927088 in treatment-naïve patients with advanced NSCLC with HER2-activating mutations
The robotic surgery program has continually pushed the boundaries of medical technology
This project is supported by the Irish Government through IDA Ireland
Subscribe To Our Newsletter & Stay Updated
